JRKL expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 6.01659833066037E-11 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.27210000042422E-07 |
Normal-vs-Stage2 |
2.642700E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
8.400000E-03 |
Stage1-vs-Stage2 |
1.345000E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
1.485240E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
4.224600E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.94549998123028E-09 |
Normal-vs-AfricanAmerican |
2.092600E-01 |
Normal-vs-Asian |
2.121800E-02 |
Caucasian-vs-AfricanAmerican |
9.641400E-01 |
Caucasian-vs-Asian |
6.320800E-01 |
AfricanAmerican-vs-Asian |
6.392400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.82690000000352E-05 |
Normal-vs-Female |
5.59970000035825E-07 |
Male-vs-Female |
2.748600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.660200E-03 |
Normal-vs-Extreme_Weight |
3.90820000000236E-05 |
Normal-vs-Obese |
3.958500E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
3.824400E-01 |
Normal_Weight-vs-Obese |
3.982000E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
9.522200E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.211200E-01 |
Normal-vs-Age(41-60Yrs) |
2.449700E-04 |
Normal-vs-Age(61-80Yrs) |
3.2402000005316E-07 |
Normal-vs-Age(81-100Yrs) |
1.820820E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.467800E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.213210E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.706160E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.994610E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.628400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.900650E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
4.410000E-01 |
Normal-vs-Grade 3 |
5.423400E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
7.666200E-01 |
Grade 2-vs-Grade 4 |
4.410000E-01 |
Grade 3-vs-Grade 4 |
5.423400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.35829996934001E-09 |
Normal-vs-N1 |
4.658000E-03 |
N0-vs-N1 |
8.240500E-04 |
|
|